Results 161 to 170 of about 6,000,234 (295)
Clinical anatomy of the musculoskeletal system in the hip region. [PDF]
Tsutsumi M, Nimura A, Akita K.
europepmc +1 more source
Unraveling the epigenetic code in cancer cell–tumor microenvironment crosstalk
Epigenetic regulation is a key driver of cancer development and progression. Diverse epigenetic alterations in cancer cells and components of the tumor microenvironment (TME) orchestrate their communication through multiple mechanisms. We discuss how the epigenetic code coordinates bidirectional cancer cell–TME crosstalk to promote cancer progression ...
Ji Hoon Park, Mi‐Young Kim
wiley +1 more source
Arginine methylation can be viewed as a persistence‐prone post‐translational modification regulated by a network of PRMTs. Competitive and compensatory interactions among PRMTs can redistribute methylation across substrate pools shaped by sequence, structural, spatial, and environmental layers, reinforcing RNA‐processing, chromatin, and signaling ...
So Hyun Kwon, Ji Min Lee
wiley +1 more source
A three-dimensional digital study on clinical anatomy of the acetabulum in elderly population aged 65-84 years in inner Mongolia, China. [PDF]
Zhenyu W +15 more
europepmc +1 more source
Clinical anatomy of the inferior labial gland: a narrative review. [PDF]
Shen D +9 more
europepmc +1 more source
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
Unveiling Guyon's Canal: Insights into Clinical Anatomy, Pathology, and Imaging. [PDF]
Saran S +7 more
europepmc +1 more source
A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination. [PDF]
Iwanaga J +5 more
europepmc +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source

